Jolanta Marzec, Lukasz Marzec, Peter Martus, Arndt-Christian Müller
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local citing links have been materialized yet.
Unresolved referenced work
2006
The radioresponsiveness of human tumours and the initial slope of the cell survival curve
10.1016/s0167-8140(84)80074-2 · 1984
Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data
10.1016/0360-3016(86)90071-4 · 1986
Radiosensitization in esophageal squamous cell carcinoma: effect of polo-like kinase 1 inhibition
10.1007/s00066-016-0951-6 · 2016
10.1007/s00066-017-1223-9
10.1007/s00066-017-1223-9
The impact of the IGF-1 system of cancer cells on radiation response 2013; An in vitro study
10.1016/j.ctro.2017.09.006 · 2017
Clonogenic assay of cells in vitro
10.1038/nprot.2006.339 · 2006
Unresolved referenced work
Kept as external metadata until matched
Parameters of linear-quadratic radiation dose-effect relationships: dependence on LET and mechanisms of reproductive cell death
10.1080/095530097143653 · 1997
The first James Kirk memorial lecture. What next in fractionated radiotherapy?
1984
The biophysical properties of 3.9-GeV nitrogen ions. VI. Interpretation of results
10.2307/3573850 · 1973
Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways
10.1016/j.bcp.2009.08.011 · 2010
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
2013
Unresolved referenced work
Kept as external metadata until matched
10.1007/3-540-31303-6
10.1007/3-540-31303-6
Final results of the randomized phase III CHARTWEL-trial (ARO 97–1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
10.1016/j.radonc.2011.06.031 · 2011
From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome
10.1053/clon.2002.0117 · 2002
The linear-quadratic formula and progress in fractionated radiotherapy
10.1259/0007-1285-62-740-679 · 1989
Time-dose factors in radiotherapy: a review of the human data
10.1016/0167-8140(90)90149-q · 1990
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction
10.1016/j.semradonc.2008.04.004 · 2008
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
10.1016/j.ijrobp.2013.07.022 · 2014
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery
10.1016/j.semradonc.2008.04.005 · 2008
Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses
10.1016/j.radonc.2013.08.027 · 2013
Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review)
10.3892/ijo.2013.1857 · 2013
No additional external references are available.
